News

Avicanna has reshaped its board, accepting the resignation of director Paul Fornazzari and appointing capital-markets veteran Michael Kott effective...

Organogenesis has begun a rolling biologics license application with the FDA for Renu, a cryopreserved amniotic suspension allograft for...

Avicanna has announced a board transition, with Paul Fornazzari stepping down and Michael Kott joining as a director on...

Amneal Pharmaceuticals and Mabxience have secured FDA approvals for Boncresa (denosumab-mobz), a biosimilar to Prolia, and Oziltus (denosumab-mobz), a...

Organogenesis has initiated a rolling BLA submission to FDA for ReNu, a cryopreserved amniotic suspension allograft for symptomatic knee...

BioAtla secured FDA alignment on the design of its Phase 3 registrational study for ozuriftamab vedotin, a ROR2-targeting ADC,...

NRx Pharmaceuticals has refiled its ANDA for KETAFREE, a preservative-free ketamine injection, and reports supportive FDA correspondence pointing to...

Inotiv posted preliminary Q4 FY2025 revenue of $137.5–138.5 million and full-year FY2025 revenue of $512.5–513.5 million, alongside a Discovery...

Cosmos Health posted record third-quarter results, with revenue up 38% year over year to $17.1 million, gross profit more...

INVO Fertility reported third-quarter 2025 revenue of $1.76 million, up 23% year over year, with consolidated clinic revenue from...